RNAi and expression of retrotransposons MuERV-L and IAP in preimplantation mouse embryos

Dev Biol. 2004 May 1;269(1):276-85. doi: 10.1016/j.ydbio.2004.01.028.

Abstract

Both murine endogenous retrovirus-L (MuERV-L) and intracisternal A particle (IAP), two autonomous long terminal repeat (LTR) retrotransposons, are activated during genome activation in the preimplantation mouse embryo, and both sense and antisense transcripts are detected in 2-cell and 8-cell stage embryos. Because RNA interference (RNAi) functions in the preimplantation mouse embryo, we analyzed the relationship between RNAi and MuERV-L and IAP expression by inhibiting RNAi and measuring relative changes of the levels of these transcripts. We inhibited the initial step in the RNAi pathway by injecting 1-cell embryos with mDicer siRNA or long mDicer dsRNA and analyzed MuERV-L and IAP expression at the 8-cell stage. This approach resulted in the targeted destruction of mDicer mRNA, but not Hdac1 mRNA, inhibited the RNAi pathway, and resulted in a 50% increase in IAP and MuERV-L transcript abundance. These results suggest that RNAi constrains expression of repetitive parasitic sequences in preimplantation embryos, and thereby contributes to preserving genomic integrity at a stage of development when the organism consists of only a few cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blastocyst / drug effects
  • Blastocyst / metabolism*
  • Genes, Intracisternal A-Particle* / drug effects
  • Mice
  • Microinjections
  • RNA Interference / physiology*
  • RNA, Double-Stranded / administration & dosage
  • RNA, Double-Stranded / pharmacology
  • RNA, Small Interfering / administration & dosage
  • RNA, Small Interfering / pharmacology
  • Retroelements* / drug effects

Substances

  • RNA, Double-Stranded
  • RNA, Small Interfering
  • Retroelements